跳至主要内容
临床试验/NCT04053998
NCT04053998已完成不适用

Benchmarking Outcomes in Pancreatoduodenectomy With Portal Vein Resection - WhippleBenchmarks.Org

Royal Free Hospital NHS Foundation Trust2 个研究点 分布在 2 个国家目标入组 1,462 人开始时间: 2019年8月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,462
试验地点
2
主要终点
Mortality rate

研究概览

简要总结

The WhippleBenchmark 2 Collaborative study aims at defining benchmark criteria for best achievable outcomes after pancreaticoduodenectomy with portal vein resection.

详细描述

Pancreatoduodenectomy (PD) with portal vein resection (PVR) is performed for the achievement of complete resection (R0) in patients with locally advanced pancreatic head lesions. Despite most commonly performed in high-volume pancreatic surgery centers by experienced surgeons, best achievable outcomes, such as morbidity and mortality, following such complex procedure remain unknown.

The aim is to conduct a retrospective multicenter cohort study to define benchmark values for best achievable outcomes following duodenopancreatectomy (DP) with portal vein resection (PVR).

Data collection and study design are based on to the well established standardized reporting for benchmarking (Sánchez-Velázquez et. al. Ann Surg, February 2019 ).

This multicenter cohort study will include all consecutive pancreaticoduodenectomies with portal vein resections from at least 20 high volume centers performing over 50 pancreatic operations per year or 150 cases within 3 years from at least 3 continents over a period of 10 years (2009-2019). Every center included in the study must have a prospective database from which data can be collected as well as previous publications critically reporting on their outcome.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults ≥ 18 years
  • Resectable malignant or benign diseases (i.e. all indications)
  • Open pancreaticoduodenectomy (all techniques allowed) with concurrent portal vein resection

排除标准

  • Patients < 18 years
  • Pancreatic resections other than pancreaticoduodenectomy and portal vein resection
  • Pancreaticoduodenectomy with arterial reconstruction
  • Laparoscopic or robotic pancreaticoduodenectomy

结局指标

主要结局

Mortality rate

时间窗: 12 months

Death due to any cause postoperatively

Morbidity rate

时间窗: 12 months

Classified according to the Clavien-Dindo Classification of postoperative complications.

Morbidity assessed according to the Comprehensive Complications Index® (CCI®)

时间窗: 12 months

The Comprehensive Complications Index® (CCI®) reports the cumulative postoperative morbidity, a novel metric which measures the overall morbidity on a scale from 0 (no complications) to 100 (death).

次要结局

  • Pancreatic fistula rates(12 months)
  • Hospital readmission rate(12 months)
  • Disease free survival rate(Up to 10 years postoperatively)

研究者

发起方
Royal Free Hospital NHS Foundation Trust
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dimitri Raptis

Senior Clinical Fellow in HPB and Transplant Surgery

Royal Free Hospital NHS Foundation Trust

研究点 (2)

Loading locations...

相似试验

Benchmarking Outcomes in Pancreatic Surgery -... | 临床试验